2025 Southeastern Residency Conference has ended

Create Your Own Event

2025 Southeastern Residency Conference

You will be able to validate your attendance (Check-In to sessions) using your personal schedule.

Graylon Cross-Penn

Piedmont Columbus Regional Midtown

PGY-1 residency

About me

Dr. Graylon Cross-Penn is originally from Huntsville, Alabama. He recieved his undergrad degree from the University of South Alabama in Mobile, Alabama. He then recieved his Doctor of Pharmacy from Auburn University in Auburn, Alabama. He is currently completing his PGY-1 residency at Piedmont Columbus Regional Midtown in Columbus, Georgia. He is interested in ambulatory care.

6:00pm EDT

Early Check-In Creature Comforts Brewery

8:00am EDT

Welcome Ballroom EFEmily Harman

8:10am EDT

Keynote Address Ballroom EFSonia Thomas

9:10am EDT

Comparative Efficacy of Ertapenem in Patients with or without Hypoalbuminemia Parthenon 2Criag MacDonald • Jakob Barton • Che Jordan

9:50am EDT

Evaluation of the Safety and Efficacy of Early Long-Acting Insulin in Diabetic Ketoacidosis Athena GSpencer Roper • Emily Davis • Vince Buttrick

11:20am EDT

Evaluating the Safety and Efficacy of Alteplase versus Tenecteplase Administration in the Management of Acute Ischemic Stroke Athena IVanessa Velazco • Brooke Landry • Adam Sawyer

12:00pm EDT

Blood Pressure Trajectory Post-Initiation of Eptinezumab Infusions For Migraines Athena IVanessa Velazco • Ashleigh Neese • Adam Sawyer

12:40pm EDT

Lunch Ballroom EF

12:45pm EDT

Product Theater Ballroom EFJJ Innovative Medicine

1:50pm EDT

Optimizing Stress Ulcer Prophylaxis in Critically Ill Patients: A Pharmacist-Driven Approach to Discontinuation Athena HJohn Carr • Ciana Wallace • Kelly Rumbaugh Evaluation of Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Non-Critically Ill Patients Olympia 2Andrew Stewart • Kelly Covert

2:10pm EDT

Evaluate safety of DPP4 inhibitors versus mealtime insulin for glycemic control in non-critically ill-hospitalized patients Parthenon 1Hania Joudeh • Graylon Cross-Penn • Jennifer Adema

3:10pm EDT

Evaluation of Intravenous Insulin Infusions in the Treatment of Mild Diabetic Ketoacidosis (DKA) Athena GApril Quidley • Janna Lewis • Christina Thurber

3:40pm EDT

Evaluating the Safety and Efficacy of an Automatic 24-hour Stop Date for Antibiotics in the Treatment of Early-Onset Sepsis in the Neonatal Intensive Care Unit Athena JDerek Gaul • Jillian Mantione • Tyler Tolbert • Tyler Tolbert

4:40pm EDT

Oral Vancomycin versus Fidaxomicin for Treatment of Initial Clostridioides Difficile Infection Parthenon 2Alexis Pruitt • Olivia Hill

9:10am EDT

Evaluation of the Impact of a Pharmacist-led Smoking Cessation Clinic Within a Primary Care Setting Athena CDevki Gajera • Tiffany Gilchrist • Erin Himes

9:30am EDT

Evaluation of a Pharmacist-Led Cardiovascular-Kidney-Metabolic (CKM) Initiative Athena CDevki Gajera • Jennie Reese • Erin Himes

10:20am EDT

Vasopressor-Sparing Effects of Methylene Blue versus Hydroxocobalamin for Vasoplegic Syndrome Post-Cardiac Surgery Parthenon 2Brook Jacobs • Cameron Garramone • Erika Ingram

10:40am EDT

Valproic Acid Augmentation in Traumatic Brain Injury Related Agitation Athena HMaggie Goode • Michelle Allsup • Madeline Motes

11:00am EDT

Evaluating the Safety and Efficacy of Bicarbonate Use in Moderate-to-Severe Diabetic Ketoacidosis Athena IAnne-Kathryn Priest • John Young • Robin Fischer Safety and Efficacy of Direct-acting Oral Anticoagulants versus Warfarin in the Treatment of Venous Thromboembolism in Severely Obese Patients Parthenon 1Matt Conley • Olukemi Omotola • Eric Marr

11:20am EDT

Impact of a Remote Continuous Glucose Monitoring Service in an Ambulatory Care Setting Athena CDevin Lavender • Alexa Williams • Crystal Wright